P28066 (PSA5_HUMAN) Homo sapiens (Human)

Proteasome subunit alpha type-5 UniProtKBInterProSTRINGInteractive Modelling

241 aa; Sequence (Fasta) ; (Isoform 2); 112 identical sequences

Available Structures

108 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human PA28-20S proteasome complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46;
1-241
100
Human PA28-20S-PA28 proteasome complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46;
1-241
100
Human 20S-PA200 Proteasome Complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
1-241
100.0IHP;K0W;
Human PA200-20S proteasome with MG-132 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
1-241
100.0LDZ;IHP;
Human PA28-20S (PA28-4a3b) Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46;
1-241
100
Human 20S proteasome assembly intermediate structure 5 Heteromer
O14818; O95456; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-241
100
Human 20S proteasome assembly intermediate structure 3 Heteromer
O14818; O95456; P25786; P25787; P25788; P25789; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-241
100.0
human PA200-20S complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
1-241
100.0K0W;IHP;
Human 20S proteasome assembly structure 1 Heteromer
O14818; O95456; P25786; P25787; P25788; P25789; P60900; Q5JS54; Q969U7; Q99436; Q9BT73; Q9Y244;
1-241
100
Human PA200-20S proteasome complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
1-241
100.0IHP;
Human proteasome alpha ring assembly intermediate Heteromer
O14818; O95456; P25786; P25787; P25788; P25789; P60900; Q5JS54; Q969U7; Q9BT73;
1-241
100
Human pre 13S proteasome assembly intermediate Heteromer
O14818; O95456; P25786; P25787; P25788; P25789; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-241
100.0
Human premature 20S proteasome assembly intermediate Heteromer
O14818; O95456; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-241
100
Akirin2 bound human proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q53H80; Q99436;
1-241
100K;
Human 20S proteasome assembly intermediate structure 4 Heteromer
O14818; O95456; P20618; P25786; P25787; P25788; P25789; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-240
100.0
Human preholo proteasome 20S core particle Heteromer
O14818; O95456; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-240
100.0
Human mixed 13S proteasome assembly intermediate Heteromer
O14818; O95456; P25786; P25787; P25788; P25789; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-239
100.0
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SC_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD4_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ADP;ATP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD5_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED4_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ADP;ATP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED1_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.0_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.1_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;MG;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED0_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED5_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
4-241
100ATP;ADP;ZN;
Human 19S-20S proteasome, state SD2 Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
5-241
100ATP;LDZ;ZN;
Human 20S proteasome assembly intermediate structure 2 Heteromer
O14818; O95456; P25786; P25787; P25788; P25789; P49720; P60900; Q969U7; Q99436; Q9Y244;
1-237
100.0
The human PI31 complexed with bovine 20S proteasome Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3SX30; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
6-241
100
The PI31-free Bovine 20S proteasome Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
6-241
100
Structure of human 20S proteasome with bound MPI-5 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6-241
100YHD;
Human 20S proteasome core particle Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
7-241
100
Structure of human constitutive 20S proteasome complexed with the inhibitor TDI-8304 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
7-241
100YRE;
Human Constitutive 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
8-241
100
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
8-241
99.1430×MG;
Human constitutive 20S proteasome in complex with carfilzomib Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
8-241
1003BV;
bovine 20S immunoproteasome Heteromer
P33672; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
8-241
100
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;
Human 20S proteasome bound to an engineered 11S (PA26) activator Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2;
8-241
100.0
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
8-241
100.0
Proteasome-ZFAND5 Complex Z+B state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ATP;ZN;
SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;AGS;
Proteasome-ZFAND5 Complex Z-C state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Bovine 20S immunoproteasome in complex with two human PA28alpha-beta activators Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
8-241
100
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ADP;ZN;
Proteasome-ZFAND5 Complex Z+A state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Proteasome-ZFAND5 Complex Z-A state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;
Proteasome-ZFAND5 Complex Z+C state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Proteasome-ZFAND5 Complex Z+E state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ATP;ZN;
SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG48; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;AGS;MG;ADP;
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ATP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SB_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in state EA1_UBL Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100ATP;MG;ADP;ZN;
Proteasome-ZFAND5 Complex Z-B state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;
Structure of USP14-bound human 26S proteasome in state EA2.0_UBL Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100ATP;MG;ADP;ZN;
PA28alpha-beta in complex with immunoproteasome Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
8-241
100
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;AGS;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ADP;ATP;MG;
Structure of USP14-bound human 26S proteasome in state EA2.1_UBL Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100ATP;MG;ADP;ZN;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;AGS;
Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;AGS;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;AGS;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;ADP;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Proteasome-ZFAND5 Complex Z+D state Heteromer
O00231; O00232; O00487; O14818; O43242; O76080; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100.0ZN;ATP;MG;ADP;
Non-substrate-engaged human 26S proteasome with Nub1/FAT10 bound to Rpn1 Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P25786; P25787; P25788; P25789; P35998; P43686; P48556; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; Q9Y5A7;
8-241
100ADP;MG;ATP;ZN;
Nub1/Fat10-processing human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P25786; P25787; P25788; P25789; P35998; P43686; P48556; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; Q9Y5A7;
8-241
100.0MG;ATP;ADP;ZN;
The human 26S proteasome at 3.9 A Heteromer
O14818; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436;
8-241
100ATP;MG;ADP;
Structure of the human 26S proteasome bound to USP14-UbAl Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
8-241
100ADP;
Native human 20S proteasome at 1.8 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
10057×CL;1PE;K; 10×MG;
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
10052×CL;K; 10×MG;1PE;6V7;
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
10051×CL;K; 10×MG;1PE;6V8;
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
10056×CL;K; 10×MG;1PE;6VC;
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
10055×CL;NEN;K; 10×MG;1PE;
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
10051×CL;K; 10×MG;1PE;BO2;
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100K; 10×MG;1PE;ACT;
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100K;MG;1PE;
Mouse 20S immunoproteasome in complex with PR-957 Heteromer
O09061; O35955; O70435; P28063; P28076; P49722; P99026; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-241
10041×CL; 13×K;04C;IOD;
Mouse constitutive 20S proteasome in complex with PR-957 Heteromer
O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-241
10004C;
Mouse 20S immunoproteasome Heteromer
O09061; O35955; O70435; P28063; P28076; P49722; P99026; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-241
10014×IOD; 23×CL; 10×K;
Mouse constitutive 20S proteasome Heteromer
O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-241
100
Human 20S proteasome with MG-132 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100LDZ;
20S+monoUb-CyclinB1-NT (S1) Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100
human 20S proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100
20S+monoUb-CyclinB1-NT (S2) Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100
Human 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100
Endogeneous native human 20S proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100
Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively … Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
9-241
100BZ7;
Bovine 20S proteasome, untreated Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
8-240
99.14
Human proteasome 20S core particle Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
100.0
Human 26S proteasome in complex with Oprozomib Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6;
9-241
100ADP;
Human 20S Proteasome in complex with peptide activator peptide BLM42 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-240
100.054×CL; 10×MG;1PE;K;
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [(1R)-2-(1-benzofuran-3-yl)-1-{[(1S,2R,4R)-7-ox… Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
9-240
100.013×NA; 11×SCN;S5K;
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin… Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
9-240
100.0SO4;NA;SKN;
Human Immunoproteasome 20S particle in complex with compound 1 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
9-240
100.0SCN; 12×NA;HUJ;
The human 26S Proteasome at 6.8 Ang. Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
10-241
100
canine immunoproteasome 20S subunit in complex with compound 1 Heteromer
A0A8C0M3N7; A0A8C0MRG6; A0A8C0N5D2; A0A8C0NHD1; A0A8C0QE86; A0A8C0QRK5; A0A8C0R9W7; A0A8C0SLB3; A0A8C0SR54; A0A8C0TD63; A0A8C0TIY6; A0A8I3PML0; Q5W412; Q5W416;
9-239
100.0A1L0C;
canine immunoproteasome 20S subunit in complex with compound 2 Heteromer
A0A8C0M3N7; A0A8C0MRG6; A0A8C0N5D2; A0A8C0NHD1; A0A8C0QE86; A0A8C0QRK5; A0A8C0R9W7; A0A8C0SLB3; A0A8C0SR54; A0A8C0T7K4; A0A8C0TD63; A0A8C0TIY6; A0A8I3PML0; Q5W416;
9-239
100A1L0D;
canine immunoproteasome 20S subunit in complex with compound 1 Heteromer
O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-239
100A1L0D;THR;
mouse proteasome 20S subunit in complex with compound 1 Heteromer
O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-239
100A1L0C;
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
13-236
100.0KNM;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8qyn.1.Dmonomer0.831-241
100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27w39.1.amonomer0.861-183
100.00